Trial Profile
A phase I trial of ISIS GCGRRx in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2012
Price :
$35
*
At a glance
- Drugs IONIS-GCGRRx (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 10 Dec 2012 Positive results were reported in an Isis Pharmaceuticals media release.
- 07 Dec 2012 Status changed from recruiting to completed.
- 04 Nov 2011 New trial record